Experimental treatment kills prostate tumor cells while reawakening antitumor immunity
Researchers at Weill Cornell Medicine have developed silica-based nanoparticles that effectively kill prostate tumor cells while boosting the body's immune response. The study, conducted on mouse models, suggests these particles could transform 'cold' tumors into 'hot' ones, potentially enhancing the efficacy of other immunotherapies.
Why it matters
This breakthrough offers a potential new clinical paradigm for treating aggressive cancers by combining direct tumor destruction with immune system activation.
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing antitumor immunity, according to a preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering.
The article reports on scientific findings from a university press release without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in